Hydrocodone Products Moving to Schedule II

As seen in the Consultant Connection October 2014 Issue

The Drug Enforcement Administration (DEA) has issued a final rule imposing stricter regulatory controls and sanctions on individuals who handle hydrocodone combination products (drugs that contain hydrocodone and specified amounts of other substances). Effective October 6, 2014, the rule moves hydrocodone combination products from Schedule III to Schedule II. Single ingredient hydrocodone products are already Schedule II medications.
The Controlled Substances Act places substances with accepted medical uses into one of four schedules, II, III, IV, or V; Schedule II is for substances with the highest potential for harm and abuse. According to an analysis by HHS and the DEA, hydrocodone combination products have a high potential for abuse, which may lead to severe psychological or physical dependence. A Food and Drug Administration advisory committee also recommended the schedule change last year.
As of October 6th, all orders for hydrocodone products must meet the requirements of a Schedule II controlled substance prescription, including the specific quantity prescribed, prescriber DEA number and manual signature of the prescriber. 
Electronic prescriptions for controlled substances are permissible, provided that the e-Prescribing software is certified as meeting DEA requirements. At present, only 30 e-Prescribing software packages meet this requirement. 

Below is an abbreviated list of Schedule II medications for your reference:
Actiq
Adderall
Adderall XL
Amphetamine Salt Combo
Amphetamine/Dextroamphetamine
Avinza
B & O Suppositories
Belladonna & Opium
Codeine Sulfate
Concerta
Demerol
Dexedrine
Dextroamphetamine Sulfate
Dilaudid
Dolophine
Duragesic
Exalgo
Fentanyl
Fentanyl Citrate
Fentora
Hydrocodone Bitartrate
Hydrocodone Polistirex
Hydrocodone/Acetaminophen
Hydrocodone/Homatropine
Hydromorphone
Hydromorphone HCl
Kadian
Lisdexamfetamine
Meperidine HCl
Methadone HCl
Hydromorphone
Hydromorphone HCl
Methadone HCL Intensol
Methylin
Methylphenidate HCl
Methylphenidate HCl ER
Morphine Sulfate
Morphine Sulfate ER
MS Contin
Hydromorphone
Hydromorphone HCl
Kadian
Lisdexamfetamine
Meperidine HCl
MS IR
Nucynta
Nucynta ER
Opana
Opana ER
Oxycodone ER
Oxycodone HCl
Oxycodone/Acetaminophen
Oxycodone/Ibuprophen
MS IR
Oxycontin
Oxymorphone ER
Oxymorphone Hydrochloride
Percoset
Ritalin
Ritalin LA
Roxanol
Roxicet
Roxicodone
Sublimaze
Tapentadol
Tapentadol ER
Tylox
Vyvanse


Back to Articles